▶ 調査レポート

トポテカンの世界市場 2020年

• 英文タイトル:Global Topotecan Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。トポテカンの世界市場 2020年 / Global Topotecan Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / GIR201115283資料のイメージです。• レポートコード:GIR201115283
• 出版社/出版日:GlobalInfoResearch / 2020年10月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、103ページ
• 納品方法:Eメール
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥508,080 (USD3,480)▷ お問い合わせ
  Multi User¥762,120 (USD5,220)▷ お問い合わせ
  Corporate User¥1,016,160 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、トポテカンの世界市場を調査対象にし、トポテカンの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(カプセル、注射)、用途別分析(卵巣がん、肺がん、その他がん)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:GSK、Dr. Reddy's Laboratories、Cipla、Teva、Pfizer、Fresenius Kabi、Mylan、Sagent Pharmaceuticals
・企業別売上、市場シェア
・トポテカンの地域別市場分析
・トポテカンの北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・トポテカンのヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・トポテカンのアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・トポテカンの南米市場規模2015-2020:ブラジル、アルゼンチンなど
・トポテカンの中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・トポテカンの種類別市場規模2015-2020:カプセル、注射
・トポテカンの用途別市場規模2015-2020:卵巣がん、肺がん、その他がん
・トポテカンの世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論

Market Overview
The global Topotecan market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Topotecan market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Topotecan market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Topotecan market has been segmented into:
Capsules
Injection

By Application, Topotecan has been segmented into:
Ovarian Cancer
Lung Cancer
Other Cancer types

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Topotecan market presented in the report. This section sheds light on the sales growth of different regional and country-level Topotecan markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Topotecan market.

The report offers in-depth assessment of the growth and other aspects of the Topotecan market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Topotecan Market Share Analysis
Topotecan competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Topotecan sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Topotecan sales, revenue and market share for each player covered in this report.

The major players covered in Topotecan are:
GSK
Dr. Reddy’s Laboratories
Cipla
Teva
Pfizer
Fresenius Kabi
Mylan
Sagent Pharmaceuticals

レポート目次

1 Topotecan Market Overview
1.1 Product Overview and Scope of Topotecan
1.2 Classification of Topotecan by Type
1.2.1 Global Topotecan Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Topotecan Revenue Market Share by Type in 2019
1.2.3 Capsules
1.2.4 Injection
1.3 Global Topotecan Market by Application
1.3.1 Overview: Global Topotecan Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Ovarian Cancer
1.3.3 Lung Cancer
1.3.4 Other Cancer types
1.4 Global Topotecan Market by Regions
1.4.1 Global Topotecan Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Topotecan (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Topotecan Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Topotecan Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Topotecan Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Topotecan Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Topotecan Status and Prospect (2015-2025)
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Topotecan Revenue, Gross Margin and Market Share (2018-2019)
2.2 Dr. Reddy’s Laboratories
2.2.1 Dr. Reddy’s Laboratories Details
2.2.2 Dr. Reddy’s Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Dr. Reddy’s Laboratories SWOT Analysis
2.2.4 Dr. Reddy’s Laboratories Product and Services
2.2.5 Dr. Reddy’s Laboratories Topotecan Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cipla
2.3.1 Cipla Details
2.3.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cipla SWOT Analysis
2.3.4 Cipla Product and Services
2.3.5 Cipla Topotecan Revenue, Gross Margin and Market Share (2018-2019)
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Teva SWOT Analysis
2.4.4 Teva Product and Services
2.4.5 Teva Topotecan Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Topotecan Revenue, Gross Margin and Market Share (2018-2019)
2.6 Fresenius Kabi
2.6.1 Fresenius Kabi Details
2.6.2 Fresenius Kabi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Fresenius Kabi SWOT Analysis
2.6.4 Fresenius Kabi Product and Services
2.6.5 Fresenius Kabi Topotecan Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mylan SWOT Analysis
2.7.4 Mylan Product and Services
2.7.5 Mylan Topotecan Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sagent Pharmaceuticals
2.8.1 Sagent Pharmaceuticals Details
2.8.2 Sagent Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sagent Pharmaceuticals SWOT Analysis
2.8.4 Sagent Pharmaceuticals Product and Services
2.8.5 Sagent Pharmaceuticals Topotecan Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Topotecan Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Topotecan Players Market Share
3.2.2 Top 10 Topotecan Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Topotecan Revenue and Market Share by Regions
4.2 North America Topotecan Revenue and Growth Rate (2015-2020)
4.3 Europe Topotecan Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Topotecan Revenue and Growth Rate (2015-2020)
4.5 South America Topotecan Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Topotecan Revenue and Growth Rate (2015-2020)
5 North America Topotecan Revenue by Countries
5.1 North America Topotecan Revenue by Countries (2015-2020)
5.2 USA Topotecan Revenue and Growth Rate (2015-2020)
5.3 Canada Topotecan Revenue and Growth Rate (2015-2020)
5.4 Mexico Topotecan Revenue and Growth Rate (2015-2020)
6 Europe Topotecan Revenue by Countries
6.1 Europe Topotecan Revenue by Countries (2015-2020)
6.2 Germany Topotecan Revenue and Growth Rate (2015-2020)
6.3 UK Topotecan Revenue and Growth Rate (2015-2020)
6.4 France Topotecan Revenue and Growth Rate (2015-2020)
6.5 Russia Topotecan Revenue and Growth Rate (2015-2020)
6.6 Italy Topotecan Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Topotecan Revenue by Countries
7.1 Asia-Pacific Topotecan Revenue by Countries (2015-2020)
7.2 China Topotecan Revenue and Growth Rate (2015-2020)
7.3 Japan Topotecan Revenue and Growth Rate (2015-2020)
7.4 Korea Topotecan Revenue and Growth Rate (2015-2020)
7.5 India Topotecan Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Topotecan Revenue and Growth Rate (2015-2020)
8 South America Topotecan Revenue by Countries
8.1 South America Topotecan Revenue by Countries (2015-2020)
8.2 Brazil Topotecan Revenue and Growth Rate (2015-2020)
8.3 Argentina Topotecan Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Topotecan by Countries
9.1 Middle East & Africa Topotecan Revenue by Countries (2015-2020)
9.2 Saudi Arabia Topotecan Revenue and Growth Rate (2015-2020)
9.3 UAE Topotecan Revenue and Growth Rate (2015-2020)
9.4 Egypt Topotecan Revenue and Growth Rate (2015-2020)
9.5 South Africa Topotecan Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Topotecan Revenue and Market Share by Type (2015-2020)
10.2 Global Topotecan Market Forecast by Type (2019-2024)
10.3 Capsules Revenue Growth Rate (2015-2025)
10.4 Injection Revenue Growth Rate (2015-2025)
11 Global Topotecan Market Segment by Application
11.1 Global Topotecan Revenue Market Share by Application (2015-2020)
11.2 Topotecan Market Forecast by Application (2019-2024)
11.3 Ovarian Cancer Revenue Growth (2015-2020)
11.4 Lung Cancer Revenue Growth (2015-2020)
11.5 Other Cancer types Revenue Growth (2015-2020)
12 Global Topotecan Market Size Forecast (2021-2025)
12.1 Global Topotecan Market Size Forecast (2021-2025)
12.2 Global Topotecan Market Forecast by Regions (2021-2025)
12.3 North America Topotecan Revenue Market Forecast (2021-2025)
12.4 Europe Topotecan Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Topotecan Revenue Market Forecast (2021-2025)
12.6 South America Topotecan Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Topotecan Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Topotecan Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Topotecan by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Topotecan Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Topotecan Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GSK Corporate Information, Location and Competitors
Table 6. GSK Topotecan Major Business
Table 7. GSK Topotecan Total Revenue (USD Million) (2017-2018)
Table 8. GSK SWOT Analysis
Table 9. GSK Topotecan Product and Solutions
Table 10. GSK Topotecan Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Dr. Reddy's Laboratories Corporate Information, Location and Competitors
Table 12. Dr. Reddy's Laboratories Topotecan Major Business
Table 13. Dr. Reddy's Laboratories Topotecan Total Revenue (USD Million) (2018-2019)
Table 14. Dr. Reddy's Laboratories SWOT Analysis
Table 15. Dr. Reddy's Laboratories Topotecan Product and Solutions
Table 16. Dr. Reddy's Laboratories Topotecan Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Cipla Corporate Information, Location and Competitors
Table 18. Cipla Topotecan Major Business
Table 19. Cipla Topotecan Total Revenue (USD Million) (2017-2018)
Table 20. Cipla SWOT Analysis
Table 21. Cipla Topotecan Product and Solutions
Table 22. Cipla Topotecan Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Teva Corporate Information, Location and Competitors
Table 24. Teva Topotecan Major Business
Table 25. Teva Topotecan Total Revenue (USD Million) (2017-2018)
Table 26. Teva SWOT Analysis
Table 27. Teva Topotecan Product and Solutions
Table 28. Teva Topotecan Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Pfizer Corporate Information, Location and Competitors
Table 30. Pfizer Topotecan Major Business
Table 31. Pfizer Topotecan Total Revenue (USD Million) (2017-2018)
Table 32. Pfizer SWOT Analysis
Table 33. Pfizer Topotecan Product and Solutions
Table 34. Pfizer Topotecan Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Fresenius Kabi Corporate Information, Location and Competitors
Table 36. Fresenius Kabi Topotecan Major Business
Table 37. Fresenius Kabi Topotecan Total Revenue (USD Million) (2017-2018)
Table 38. Fresenius Kabi SWOT Analysis
Table 39. Fresenius Kabi Topotecan Product and Solutions
Table 40. Fresenius Kabi Topotecan Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Mylan Corporate Information, Location and Competitors
Table 42. Mylan Topotecan Major Business
Table 43. Mylan Topotecan Total Revenue (USD Million) (2017-2018)
Table 44. Mylan SWOT Analysis
Table 45. Mylan Topotecan Product and Solutions
Table 46. Mylan Topotecan Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Sagent Pharmaceuticals Corporate Information, Location and Competitors
Table 48. Sagent Pharmaceuticals Topotecan Major Business
Table 49. Sagent Pharmaceuticals Topotecan Total Revenue (USD Million) (2017-2018)
Table 50. Sagent Pharmaceuticals SWOT Analysis
Table 51. Sagent Pharmaceuticals Topotecan Product and Solutions
Table 52. Sagent Pharmaceuticals Topotecan Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Topotecan Revenue (Million USD) by Players (2015-2020)
Table 54. Global Topotecan Revenue Share by Players (2015-2020)
Table 55. Global Topotecan Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Topotecan Revenue Market Share by Regions (2015-2020)
Table 57. North America Topotecan Revenue by Countries (2015-2020)
Table 58. North America Topotecan Revenue Market Share by Countries (2015-2020)
Table 59. Europe Topotecan Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Topotecan Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Topotecan Revenue by Countries (2015-2020)
Table 62. South America Topotecan Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Topotecan Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Topotecan Revenue Market Share by Countries (2015-2020)
Table 65. Global Topotecan Revenue (Million USD) by Type (2015-2020)
Table 66. Global Topotecan Revenue Share by Type (2015-2020)
Table 67. Global Topotecan Revenue Forecast by Type (2021-2025)
Table 68. Global Topotecan Revenue by Application (2015-2020)
Table 69. Global Topotecan Revenue Share by Application (2015-2020)
Table 70. Global Topotecan Revenue Forecast by Application (2021-2025)
Table 71. Global Topotecan Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Topotecan Picture
Figure 2. Global Topotecan Revenue Market Share by Type in 2019
Figure 3. Capsules Picture
Figure 4. Injection Picture
Figure 5. Topotecan Revenue Market Share by Application in 2019
Figure 6. Ovarian Cancer Picture
Figure 7. Lung Cancer Picture
Figure 8. Other Cancer types Picture
Figure 9. Global Topotecan Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Topotecan Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Topotecan Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Topotecan Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Topotecan Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Topotecan Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Topotecan Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Topotecan Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Topotecan Revenue Market Share in 2019
Figure 18. Global Top 10 Players Topotecan Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Topotecan Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Topotecan Revenue Market Share by Regions (2015-2020)
Figure 22. Global Topotecan Revenue Market Share by Regions in 2018
Figure 23. North America Topotecan Revenue and Growth Rate (2015-2020)
Figure 24. Europe Topotecan Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Topotecan Revenue and Growth Rate (2015-2020)
Figure 26. South America Topotecan Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Topotecan Revenue and Growth Rate (2015-2020)
Figure 28. North America Topotecan Revenue Market Share by Countries (2015-2020)
Figure 29. North America Topotecan Revenue Market Share by Countries in 2019
Figure 30. USA Topotecan Revenue and Growth Rate (2015-2020)
Figure 31. Canada Topotecan Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Topotecan Revenue and Growth Rate (2015-2020)
Figure 33. Europe Topotecan Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Topotecan Revenue Market Share by Countries in 2019
Figure 35. Germany Topotecan Revenue and Growth Rate (2015-2020)
Figure 36. UK Topotecan Revenue and Growth Rate (2015-2020)
Figure 37. France Topotecan Revenue and Growth Rate (2015-2020)
Figure 38. Russia Topotecan Revenue and Growth Rate (2015-2020)
Figure 39. Italy Topotecan Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Topotecan Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Topotecan Revenue Market Share by Countries in 2019
Figure 42. China Topotecan Revenue and Growth Rate (2015-2020)
Figure 43. Japan Topotecan Revenue and Growth Rate (2015-2020)
Figure 44. Korea Topotecan Revenue and Growth Rate (2015-2020)
Figure 45. India Topotecan Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Topotecan Revenue and Growth Rate (2015-2020)
Figure 47. South America Topotecan Revenue Market Share by Countries (2015-2020)
Figure 48. South America Topotecan Revenue Market Share by Countries in 2019
Figure 49. Brazil Topotecan Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Topotecan Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Topotecan Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Topotecan Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Topotecan Revenue and Growth Rate (2015-2020)
Figure 54. UAE Topotecan Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Topotecan Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Topotecan Revenue and Growth Rate (2015-2020)
Figure 57. Global Topotecan Revenue Share by Type (2015-2020)
Figure 58. Global Topotecan Revenue Share by Type in 2019
Figure 59. Global Topotecan Market Share Forecast by Type (2021-2025)
Figure 60. Global Capsules Revenue Growth Rate (2015-2020)
Figure 61. Global Injection Revenue Growth Rate (2015-2020)
Figure 62. Global Topotecan Revenue Share by Application (2015-2020)
Figure 63. Global Topotecan Revenue Share by Application in 2019
Figure 64. Global Topotecan Market Share Forecast by Application (2021-2025)
Figure 65. Global Ovarian Cancer Revenue Growth Rate (2015-2020)
Figure 66. Global Lung Cancer Revenue Growth Rate (2015-2020)
Figure 67. Global Other Cancer types Revenue Growth Rate (2015-2020)
Figure 68. Global Topotecan Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Topotecan Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Topotecan Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Topotecan Revenue Market Forecast (2021-2025)
Figure 72. Europe Topotecan Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Topotecan Revenue Market Forecast (2021-2025)
Figure 74. South America Topotecan Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Topotecan Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel